BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37776258)

  • 21. Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms.
    Kavus H; Ding Y; Dhesi M
    Arch Pathol Lab Med; 2024 Mar; 148(3):292-298. PubMed ID: 37270801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.
    Buske C; Hutchings M; Ladetto M; Goede V; Mey U; Soubeyran P; Spina M; Stauder R; Trněný M; Wedding U; Fields P;
    Ann Oncol; 2018 Mar; 29(3):544-562. PubMed ID: 29194473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging prognostic factors in diffuse large B cell lymphoma.
    Gascoyne RD
    Curr Opin Oncol; 2004 Sep; 16(5):436-41. PubMed ID: 15314511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
    Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric-type Follicular Lymphoma and Pediatric Nodal Marginal Zone Lymphoma: Recent Clinical, Morphologic, Immunophenotypic, and Genetic Insights.
    Koo M; Ohgami RS
    Adv Anat Pathol; 2017 May; 24(3):128-135. PubMed ID: 28277421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary mediastinal B-cell lymphoma: treatment and therapeutic targets.
    Rodríguez J; Gutiérrez A; Piris M
    Leuk Lymphoma; 2008 Jun; 49(6):1050-61. PubMed ID: 18452109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.
    Raess PW; Moore SR; Cascio MJ; Dunlap J; Fan G; Gatter K; Olson SB; Braziel RM
    Leuk Lymphoma; 2018 Jun; 59(6):1391-1398. PubMed ID: 28868942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.
    Al Kuraya K; Siraj AK; Bavi P; Al-Jomah N; El-Solh H; Ezzat A; Al-Dayel F; Belgaumi A; Al-Kofide A; Sabbah R; Sheikh S; Amr S; Simon R; Sauter G
    Mod Pathol; 2006 Aug; 19(8):1124-9. PubMed ID: 16715073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.
    Boyer DF; McKelvie PA; de Leval L; Edlefsen KL; Ko YH; Aberman ZA; Kovach AE; Masih A; Nishino HT; Weiss LM; Meeker AK; Nardi V; Palisoc M; Shao L; Pittaluga S; Ferry JA; Harris NL; Sohani AR
    Am J Surg Pathol; 2017 Mar; 41(3):299-312. PubMed ID: 28195879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New horizons in bladder cancer research.
    Boormans JL; Zwarthoff EC; Black PC; Goebell PJ; Kamat AM; Nawroth R; Seiler R; Williams SB; Schmitz-Dräger BJ
    Urol Oncol; 2020 Dec; 38(12):867-885. PubMed ID: 30852032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers.
    Wang MX; Wang HY; Zhao X; Srilatha N; Zheng D; Shi H; Ning J; Duff DJ; Taylor KH; Gruner BA; Caldwell CW
    Int J Clin Exp Pathol; 2010 Jan; 3(3):265-79. PubMed ID: 20224725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytologic perspectives on neoteric B-cell lymphoproliferative disorders.
    Sturgis CD; Monaco SE; Sakr H; Pantanowitz L
    Diagn Cytopathol; 2017 Nov; 45(11):1005-1019. PubMed ID: 28594112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of systemic metastatic retinal lymphoma.
    Cao X; Shen D; Callanan DG; Mochizuki M; Chan CC
    Acta Ophthalmol; 2011 Mar; 89(2):e149-54. PubMed ID: 19958292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.
    Ok CY; Medeiros LJ; Thakral B; Tang G; Jain N; Jabbour E; Pierce SA; Konoplev S
    Mod Pathol; 2019 Jan; 32(1):48-58. PubMed ID: 30181564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.